Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual SummitFireside Chat: Monday, April 24, 2023 at 9:30 am ET

H.C. Wainwright BioConnect Investor Conference Fireside Chat: Tuesday, May 2, 2023 at 12:00 pm ETLocation: Nasdaq World Headquarters, New York, NY

The JMP Securities Life Sciences ConferenceFireside Chat: Tuesday, May 16, 2023 at 3:00 pm ETLocation: New York Hilton Midtown, New York, NY

A live webcast and archived replay of the fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Investors & MediaSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• The King Center and Divine Nine Launch Historic Fundraising Campaign to Preserve Critical History and Amplify Nonviolence365® Ahead of King100
• Bell Medical Announces Partnership with Feellife
• Litecoin Price Prediction Drowns 89% Below Its Peak While Pepeto Rockets